DanielM.MusherMD

Infectious Disease • Houston, TX

Professor, Medicine, Baylor College of Medicine

Join to view full profile

Dr. Musher is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Musher's full profile

Already have an account?

Office
2002 Holcombe Blvd
Houston, TX 77030
Phone+1 713-794-7386

Education & Training

Tufts Medical CenterFellowship, Infectious Disease, 1969 - 1971
Tufts Medical CenterResidency, Internal Medicine, 1967 - 1968
NYU Grossman School of MedicineResidency, Internal Medicine, 1964 - 1965
NYU Grossman School of MedicineInternship, Transitional Year, 1963 - 1964
Columbia University Vagelos College of Physicians and SurgeonsClass of 1963

Certifications & Licensure

TX State Medical License 1971 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

Elected Member The American Society for Clinical Investigation, 1980
Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection Start of enrollment: 2004 Jan 01
Completed
Phase 3
Response of Clostridium Difficile Infection to Metronidazole Therapy Start of enrollment: 2005 Jun 01
Completed
Humoral Determinants of Immunity to Pneumococcal Infection Start of enrollment: 2003 Jan 01
Completed
Phase 4
Pulmonary Infections Masquerading as Community-Acquired Pneumonia Start of enrollment: 2004 Jan 01
Completed
Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody Start of enrollment: 2005 Jan 01
Completed
Vancomycin vs. Vancomycin Plus Gentamycin in Treatment of MRSA Infection Start of enrollment: 2006 Jan 01
Completed
Phase 4
Addition of Lactobacillus to Metronidazole in Treatment of CDAD Start of enrollment: 2008 Aug 01
Withdrawn
Phase 4
Fecal Bacterial Flora in Clostridium Difficile-Associated Diarrhea Start of enrollment: 2005 Oct 01
Completed
Vancomycin vs. Nitazoxanide to Treat Recurrent C. Difficile Colitis Start of enrollment: 2006 Jan 01
Completed
Chart Review of Outcome of Treatment for S. Aureus Bacteremia Start of enrollment: 2006 Feb 01
Completed
Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated Disease Start of enrollment: 2006 Dec 01
Terminated
Phase 3
Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis Start of enrollment: 2004 Jan 01
Completed
Phase 2
Efficacy of Loperamide for C. Difficile Colitis and Other Diarrheal Diseases Associated With Antibiotic Therapy Start of enrollment: 2007 Oct 01
Suspended
Phase 4
Rapid Test to Detect Staphylococcus Aureus in Blood and Wound Infections Start of enrollment: 2008 Apr 01
Completed
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP Start of enrollment: 2012 Oct 01
Withdrawn
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Pleural Empyema: Etiology and Pathogenesis.
Daniel M Musher, Sherwood Gorbach, Joshua Fierer
Clinical Infectious Diseases. 2024-12-17
Constructing an Ideal History of Present Illness: Prescriptions for Medical Educators and Trainees.
Eleanor E A Smith, Daniel M Musher, Prathit A Kulkarni
The American Journal of Medicine. 2024-12-01
1 citations
Is it time to retire the term 'bloodstream infection'? (Submitted as Letter to the Editor).
Daniel M Musher, Francisco X Elisarraras
The Journal of Infection. 2024-07-01

Other

Pneumococcal vaccination in adults
Musher DM
http://www.uptodate.com/contents/pneumococcal-vaccination-in-adults
UpToDate, Wolters Kluwer Health - 2013-04-18
Resistance of Streptococcus pneumoniae to beta-lactam antibiotics
Musher DM
http://www.uptodate.com/contents/resistance-of-streptococcus-pneumoniae-to-beta-lactam-antibiotics
UpToDate, Wolters Kluwer Health - 2013-02-28
Resistance of Streptococcus pneumoniae to the fluoroquinolones, doxycycline, and trimethoprim-sulfamethoxazole
Musher DM
http://www.uptodate.com/contents/resistance-of-streptococcus-pneumoniae-to-the-fluoroquinolones-doxy
UpToDate, Wolters Kluwer Health - 2012-01-06
Resistance of Streptococcus pneumoniae to the macrolides, azalides, lincosamines, and ketolides
Musher DM
http://www.uptodate.com/contents/resistance-of-streptococcus-pneumoniae-to-the-macrolides-azalides-l
UpToDate, Wolters Kluwer Health - 2013-01-03
Join now to see all

Press Mentions

A Back to Work ID Link-O-ramaSeptember 8th, 2022
Despite New Infections, Officials Say High School TB Outbreak ContainedAugust 23rd, 2017

DanielM.MusherMD

Dr. Musher is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.